Jeanne Holden-Wiltse
Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Anti-HIV Agents | 6 | 1996 | 44 |
Why?
|
HIV Infections | 7 | 1996 | 137 |
Why?
|
HIV-1 | 6 | 1996 | 93 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2007 | 17 |
Why?
|
Food Preferences | 2 | 1992 | 11 |
Why?
|
Influenza Vaccines | 2 | 2007 | 70 |
Why?
|
HIV Protease Inhibitors | 2 | 1997 | 25 |
Why?
|
Taste | 1 | 1992 | 10 |
Why?
|
Influenza A Virus, H3N2 Subtype | 2 | 2007 | 21 |
Why?
|
Obesity | 2 | 1992 | 149 |
Why?
|
Body Weight | 1 | 1992 | 178 |
Why?
|
HIV Protease | 1 | 2010 | 7 |
Why?
|
Drug Resistance, Viral | 1 | 2010 | 17 |
Why?
|
Delavirdine | 2 | 1999 | 7 |
Why?
|
Lymphocyte Subsets | 1 | 2009 | 26 |
Why?
|
Virus Replication | 2 | 1997 | 90 |
Why?
|
Blood | 1 | 2009 | 67 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 1998 | 41 |
Why?
|
Orthomyxoviridae Infections | 1 | 2010 | 29 |
Why?
|
Influenza A virus | 1 | 2009 | 63 |
Why?
|
Influenza, Human | 1 | 2009 | 94 |
Why?
|
B-Lymphocytes | 1 | 2009 | 134 |
Why?
|
Adult | 13 | 1992 | 1321 |
Why?
|
RNA, Viral | 6 | 1996 | 91 |
Why?
|
Antiprotozoal Agents | 1 | 2001 | 1 |
Why?
|
Pyrimethamine | 1 | 2001 | 2 |
Why?
|
Toxoplasmosis | 1 | 2001 | 5 |
Why?
|
Antiviral Agents | 2 | 1996 | 91 |
Why?
|
Reverse Transcriptase Inhibitors | 2 | 1998 | 19 |
Why?
|
Azithromycin | 1 | 2001 | 13 |
Why?
|
CD4 Lymphocyte Count | 5 | 1996 | 50 |
Why?
|
HIV Reverse Transcriptase | 2 | 1998 | 16 |
Why?
|
Encephalitis | 1 | 2001 | 29 |
Why?
|
Middle Aged | 9 | 1992 | 1166 |
Why?
|
Perylene | 1 | 1999 | 1 |
Why?
|
Female | 12 | 1992 | 1646 |
Why?
|
Humans | 15 | 1992 | 1858 |
Why?
|
Sarcoma, Kaposi | 1 | 1998 | 15 |
Why?
|
Models, Theoretical | 2 | 2009 | 124 |
Why?
|
Piperazines | 1 | 1998 | 57 |
Why?
|
Sesquiterpenes | 1 | 1998 | 24 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1998 | 35 |
Why?
|
Male | 12 | 1992 | 1558 |
Why?
|
Urea | 1 | 1997 | 31 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1999 | 85 |
Why?
|
Didanosine | 1 | 1996 | 8 |
Why?
|
Anti-Bacterial Agents | 1 | 2001 | 195 |
Why?
|
Ribavirin | 1 | 1996 | 23 |
Why?
|
Half-Life | 2 | 1998 | 69 |
Why?
|
Skin Neoplasms | 1 | 1998 | 97 |
Why?
|
Mice, Inbred C57BL | 2 | 2009 | 318 |
Why?
|
Mutation | 1 | 2000 | 340 |
Why?
|
Drug Therapy, Combination | 3 | 1996 | 189 |
Why?
|
Dietary Carbohydrates | 1 | 1992 | 23 |
Why?
|
Dietary Fats | 1 | 1992 | 33 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1998 | 431 |
Why?
|
Virology | 1 | 2010 | 13 |
Why?
|
Adolescent | 2 | 1992 | 892 |
Why?
|
Virulence | 1 | 2010 | 48 |
Why?
|
Hong Kong | 1 | 2009 | 11 |
Why?
|
Immunoglobulin M | 1 | 2010 | 82 |
Why?
|
Cross Reactions | 1 | 2009 | 65 |
Why?
|
Drug Resistance, Microbial | 2 | 1998 | 53 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2010 | 52 |
Why?
|
HIV Core Protein p24 | 2 | 1998 | 17 |
Why?
|
Immunologic Memory | 1 | 2009 | 51 |
Why?
|
Viral Load | 2 | 1998 | 53 |
Why?
|
Mice | 2 | 2009 | 623 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 224 |
Why?
|
Epithelial Cells | 1 | 2010 | 135 |
Why?
|
Immunodiffusion | 1 | 2007 | 30 |
Why?
|
Immunoglobulin G | 1 | 2010 | 192 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 2007 | 28 |
Why?
|
Baculoviridae | 1 | 2007 | 23 |
Why?
|
Vaccines, DNA | 1 | 2007 | 16 |
Why?
|
Antibodies, Viral | 1 | 2010 | 104 |
Why?
|
Computer Simulation | 1 | 2009 | 134 |
Why?
|
Influenza B virus | 1 | 2007 | 16 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 322 |
Why?
|
Drug Administration Schedule | 2 | 1997 | 193 |
Why?
|
Cohort Studies | 2 | 1998 | 333 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2007 | 27 |
Why?
|
Animals | 3 | 2001 | 1032 |
Why?
|
Double-Blind Method | 1 | 2007 | 274 |
Why?
|
Models, Biological | 1 | 2009 | 411 |
Why?
|
Child | 1 | 1992 | 750 |
Why?
|
Time Factors | 1 | 2010 | 896 |
Why?
|
Lung | 1 | 2009 | 233 |
Why?
|
Toxoplasma | 1 | 2001 | 5 |
Why?
|
Dermatitis, Phototoxic | 1 | 1999 | 5 |
Why?
|
Injections, Intravenous | 1 | 1999 | 105 |
Why?
|
Drug Eruptions | 1 | 1998 | 26 |
Why?
|
Statistics, Nonparametric | 1 | 1999 | 142 |
Why?
|
Zalcitabine | 1 | 1997 | 6 |
Why?
|
Administration, Oral | 1 | 1999 | 170 |
Why?
|
Area Under Curve | 1 | 1998 | 48 |
Why?
|
Cyclohexanes | 1 | 1998 | 15 |
Why?
|
Leukocytes, Mononuclear | 1 | 1998 | 67 |
Why?
|
Injections, Subcutaneous | 1 | 1997 | 63 |
Why?
|
Zidovudine | 1 | 1997 | 23 |
Why?
|
Giant Cells | 1 | 1996 | 11 |
Why?
|
Interferon-alpha | 1 | 1997 | 43 |
Why?
|
Viremia | 1 | 1996 | 18 |
Why?
|
Drug Interactions | 1 | 1996 | 111 |
Why?
|
Genetic Variation | 1 | 1996 | 92 |
Why?
|
Recombinant Proteins | 1 | 1997 | 290 |
Why?
|
Molecular Sequence Data | 1 | 2000 | 404 |
Why?
|
Follow-Up Studies | 1 | 1999 | 554 |
Why?
|
Treatment Outcome | 1 | 2001 | 662 |
Why?
|
United States | 1 | 2001 | 604 |
Why?
|
Dietary Proteins | 1 | 1992 | 26 |
Why?
|
Food | 1 | 1992 | 15 |
Why?
|
Cells, Cultured | 1 | 1998 | 447 |
Why?
|
